Search

Author/Creator Penson, Richard

1. Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy. (November 2020)

Authors:
Tjokrowidjaja, Angelina; Lee, Chee K.; Friedlander, Michael; Gebski, Val; Gladieff, Laurence; Ledermann, Jonathan; Penson, Richard; Oza, Amit; Korach, Jacob; Huzarski, Tomasz; Manso, Luis; Pisano, Carmela; Asher, Rebecca; Lord, Sarah J.; Kim, Se Ik; Lee, Jung-Yun; Colombo, Nicoletta; Park-Simon, ...
Journal:
European journal of cancer
Issue:
Volume 139(2020)
Page Start:
59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A; Asher, Rebecca; Penson, Richard T; Oza, Amit M; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Elias A...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
620
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗